Our monthly plan is $500 ($50 off, new client special)
If a provider determines that GLP-1 treatment is not appropriate for a given patient, no medication is prescribed
Dorr et al., Evaluation of Melanotan-ll, A Superpotent Cyclic Melanotropic Peptide in a Pilot Phase-I Clinical Study
Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK
(If you have done the Cognitive Function Test already LOGIN first to save time.)
Multivariate analysis revealed some predictive factors of 90 th -day poor clinical outcomes, including older age (OR 1.12, p = 0.007), male sex (OR 14.56, p = 0.023), predominant hemisphere lesion (OR12.30, p = 0.026), increased NIHSS of 2 points (OR 34.47, p = 0.006), and large artery atherosclerosis classification (OR 13.08, p = 0.016)